Cargando…

In vitro evaluation of the activity of teriflunomide against SARS-CoV-2 and the human coronaviruses 229E and OC43

Previous data have suggested an antiviral effect of teriflunomide, including against severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), the agent underlying the ongoing COVID-19 pandemic. We undertook an in vitro investigation to evaluate the inhibitory activity of teriflunomide against S...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lang, Paul, Geertsen, Svend S., Lublin, Alex L., Potter, Michelle C., Gladysheva, Tatiana, Gregory, Jill S., Rufi, Pascal
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2022
Materias:	Short Communication
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9682045/ https://www.ncbi.nlm.nih.gov/pubmed/36437966 http://dx.doi.org/10.1016/j.bbrep.2022.101395

Ejemplares similares

Vaccine Response in Patients With Multiple Sclerosis Receiving Teriflunomide
por: Tornatore, Carlo, et al.
Publicado: (2022)

Circulation of human coronaviruses OC43 and 229E in Córdoba, Argentina
por: Ottogalli, María Emilia, et al.
Publicado: (2021)

Improved plaque assay for human coronaviruses 229E and OC43
por: Bracci, Nicole, et al.
Publicado: (2020)

Production of specific antibodies against SARS-coronavirus nucleocapsid protein without cross reactivity with human coronaviruses 229E and OC43
por: Lee, Hyun-Kyoung, et al.
Publicado: (2010)

Human Coronavirus-229E, -OC43, -NL63, and -HKU1 (Coronaviridae)
por: Liu, Ding X., et al.
Publicado: (2021)

Clinical Impact of Human Coronaviruses 229E and OC43 Infection in Diverse Adult Populations
por: Walsh, Edward E., et al.
Publicado: (2013)

Evaluation of nested polymerase chain methods for the detection of human coronaviruses 229E and OC43
por: Myint, S., et al.
Publicado: (1994)

Direct diagnosis of human respiratory coronaviruses 229E and OC43 by the polymerase chain reaction
por: Vabret, Astrid, et al.
Publicado: (2001)

Comparison of the clinical characteristics and mortality of adults infected with human coronaviruses 229E and OC43
por: Choi, Won-Il, et al.
Publicado: (2021)

Evidence for adaptive evolution in the receptor-binding domain of seasonal coronaviruses OC43 and 229e
por: Kistler, Kathryn E, et al.
Publicado: (2021)

Seasonality of Coronavirus 229E, HKU1, NL63, and OC43 From 2014 to 2020
por: Rucinski, Stefanea L., et al.
Publicado: (2020)

Clinico-epidemiological characteristics of acute respiratory infections by coronavirus OC43, NL63 and 229E()
por: Reina, J., et al.
Publicado: (2014)

Adaptation of the endemic coronaviruses HCoV-OC43 and HCoV-229E to the human host
por: Forni, Diego, et al.
Publicado: (2021)

Correction: Evidence for adaptive evolution in the receptor-binding domain of seasonal coronaviruses OC43 and 229e
por: Kistler, Kathryn E, et al.
Publicado: (2022)

Seroepidemiology of the Seasonal Human Coronaviruses NL63, 229E, OC43 and HKU1 in France
por: De Thoisy, Alix, et al.
Publicado: (2023)

The RNA of human coronavirus OC-43
por: Tannock, Gregory A., et al.
Publicado: (1977)

Titration of Human Coronaviruses, HCoV-229E and HCoV-OC43, by an Indirect Immunoperoxidase Assay
por: Lambert, Francine, et al.
Publicado: (2007)

Prevalence of antibody to human coronaviruses 229E, OC43 and neonatal calf diarrhea coronavirus (NCDCV) in patients of Northern Italy
por: Cereda, P. M., et al.
Publicado: (1986)

Intensive care admission for Coronavirus OC43 respiratory tract infections
por: Vandroux, D., et al.
Publicado: (2018)

Comparison of immunofluorescence with monoclonal antibodies and RT-PCR for the detection of human coronaviruses 229E and OC43 in cell culture
por: Sizun, Jacques, et al.
Publicado: (1998)

Molecular evolution of human coronavirus-NL63, -229E, -HKU1 and -OC43 in hospitalized children in China
por: Shao, Nan, et al.
Publicado: (2022)

Interferon regulatory factor 3 mediates effective antiviral responses to human coronavirus 229E and OC43 infection
por: Duncan, Joseph K. Sampson, et al.
Publicado: (2023)

Climate and Human coronaviruses 229E and Human coronaviruses OC43 Infections: Respiratory Viral Infections Prevalence in Hospitalized Children in Cheonan, Korea
por: Kim, Jang Mook, et al.
Publicado: (2020)

Protein composition of coronavirus OC 43
por: Hierholzer, J.C., et al.
Publicado: (1972)

Plasma neurofilament light chain in children with relapsing MS receiving teriflunomide or placebo: A post hoc analysis of the randomized TERIKIDS trial
por: Kuhle, Jens, et al.
Publicado: (2023)

Surveillance of endemic human coronaviruses (HCoV-NL63, OC43 and 229E) associated with childhood pneumonia in Kilifi, Kenya
por: Otieno, Grieven P., et al.
Publicado: (2020)

Características de las infecciones respiratorias agudas causadas por los coronavirus OC43, NL63 y 229E
por: Reina, J., et al.
Publicado: (2014)

Survival of human coronaviruses 229E and OC43 in suspension and after drying onsurfaces: a possible source ofhospital-acquired infections
por: Sizun, J, et al.
Publicado: (2000)

Seroprevalence and SARS-CoV-2 cross-reactivity of endemic coronavirus OC43 and 229E antibodies in Finnish children and adults
por: Tamminen, Kirsi, et al.
Publicado: (2021)

Immunodetection assays for the quantification of seasonal common cold coronaviruses OC43, NL63, or 229E infection confirm nirmatrelvir as broad coronavirus inhibitor
por: Weil, Tatjana, et al.
Publicado: (2022)

Less severe course of COVID-19 is associated with elevated levels of antibodies against seasonal human coronaviruses OC43 and HKU1 (HCoV OC43, HCoV HKU1)
por: Dugas, Martin, et al.
Publicado: (2021)

Epidemiology of the four human coronaviruses 229E, HKU1, NL63 and OC43 detected over 30 months in the Singapore military
por: Liaw, C.W.J., et al.
Publicado: (2012)

Clinical Study of Human Coronavirus NL63, OC43, 229E, HKU1 Infentions in Hospitalized Children from 2015 to 2020
por: Wen, Chan, et al.
Publicado: (2022)

Structural proteins of human respiratory coronavirus OC43
por: Hogue, Brenda G., et al.
Publicado: (1986)

Apoptosis Enhances the Replication of Human Coronavirus OC43
por: Maharjan, Sony, et al.
Publicado: (2021)

Optimizing human coronavirus OC43 growth and titration
por: Savoie, Christopher, et al.
Publicado: (2022)

Heparan Sulfate and Enoxaparin Interact at the Interface of the Spike Protein of HCoV-229E but Not with HCoV-OC43
por: Fuochi, Virginia, et al.
Publicado: (2023)

Improving human coronavirus OC43 (HCoV-OC43) research comparability in studies using HCoV-OC43 as a surrogate for SARS-CoV-2
por: Schirtzinger, Erin E., et al.
Publicado: (2022)

Genetic Characterisation and Comparison of Three Human Coronaviruses (HKU1, OC43, 229E) from Patients and Bovine Coronavirus (BCoV) from Cattle with Respiratory Disease in Slovenia
por: Jevšnik Virant, Monika, et al.
Publicado: (2021)

Activation of glial cells by human coronavirus OC43 infection
por: Edwards, Julie A, et al.
Publicado: (2000)

Cannot write session to /tmp/vufind_sessions/sess_4riod7oiq15iifgk9cabo0pljo